4893 items matching your search terms.

Population case-control study of cerebral palsy: neonatal predictors for low-risk term singletons

McIntyre, S Badawi, N Brown, C Blair, E.
PEDIATRICS, 2011     DOI:10.1542/peds.2010-1894

BRAF mutation by age-decade and body mass index in metastatic melanoma

Menzies, AM Visintin, L Chatfield, MD Carlino, MS Howle, JR Scolyer, RA Thompson, F Kefford, RF Long, GV

Variables predicting change in benign melanocytic nevi undergoing short-term dermoscopic imaging

Menzies, SW Stevenson, ML Altamura, D Byth, K
ARCHIVES OF DERMATOLOGY, 2011     DOI:10.1001/archdermatol.2011.133

Smaller fetal thymuses in pre-eclampsia: a prospective cross-sectional study

Mohamed, N Eviston, DP Quinton, AE Benzie, RJ Kirby, AC Peek, MJ Nanan, RK
ULTRASOUND IN OBSTETRICS AND GYNECOLOGY, 2011     DOI:10.1002/uog.8953

Clinical and pathological features of metastases of primary cutaneous desmoplastic melanoma

Murali, R Zannino, D Synnott, M McCarthy, SW Thompson, JF Scolyer, RA
HISTOPATHOLOGY, 2011     DOI:10.1111/j.1365-2559.2011.03808.x

Can urodynamic stress incontinence be diagnosed by ultrasound?

Nazemian, K Shek, K Martin, A Dietz, H

Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of Vater

Neoptolemos, JP Moore, MJ Cox, TF Valle, JW Palmer, DH McDonald, A Carter, R Tebbutt, NC Dervenis, C Smith, D Glimelius, B Coxon, FY Lacaine, F Middleton, R Ghaneh, P Bassi, C Halloran, C Olah, A Rawcliffe, CL Büchler, MW European Study Group for Pancreatic Cancer,

The utility of preoperative CA-125 in the management of apparent early-stage endometrial cancer

Nicklin, J Janda, M Gebski, V Jobling, T Land, R Manolitsas, T McCartney, A Nascimento, M Perrin, L Obermair, A

Internal mammary lymph node metastasis in breast cancer: Predictive models to assist with prognostic influence

Noushi, F Spillane, AJ Uren, RF Gebski, V
BREAST, 2011     DOI:10.1016/j.breast.2010.12.008

Relationship between the development of rash and clinical and health-related quality of life outcomes by KRAS mutation status in colorectal cancer patients treated with cetuximab in NCIC CTG CO.17

O'Callaghan, CJ Tu, D Karapetis, CS Au, HJ Moore, MJ Tebbutt, NC Trudeau, MG Price, TJ Yip, D Jonker, DJ

Phase 2 trial of aprepitant on days 1–7 for patients with germ cell tumours having cisplatin on days 1–5

Olver, I Grimison, P Chatfield, M Stockler, MR Toner, G Gebski, V Harrup, RA Underhill, C Kichenadasse, G Singhal, N Boland, AL McDonald, A Thomson, DB Australian and New Zealand Urogenital and Prostate Cancer Trials Group,

Re: Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46 [letter]

Ooi, WL Stockler, M Hayne, D
EUROPEAN UROLOGY, 2011     DOI:10.1016/j.eururo.2011.03.050

SCOT: Short Course Oncology Therapy—a comparison of 12 and 24 weeks of adjuvant chemotherapy in colorectal cancer

Paul, J Briggs, A Harkin, A Haydon, AM Iveson, T Masterson, M Midgley, RA Cassidy, J

A phase 3 trial of bevacizumab in ovarian cancer

Perren, TJ Swart, AM Pfisterer, J Ledermann, JA Pujade-Lauraine, E Kristensen, G Carey, MS Beale, P Cervantes, A Kurzeder, C du Bois, A Sehouli, J Kimmig, R Stähle, A Collinson, F Essapen, S Gourley, C Lortholary, A Selle, F Mirza, MR Leminen, A Plante, M Stark, D Qian, W Parmar, MK Oza, AM ICON7 Investigators,

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

Phillips, KA Aldridge, J Ribi, K Sun, Z Thompson, A Harvey, V Thürlimann, B Cardoso, F Pagani O, Coates, AS Goldhirsch, A Price, KN Gelber, RD Bernhard, J
BREAST CANCER RESEARCH AND TREATMENT, 2011     DOI:10.1007/s10549-010-1235-y